baber/WOPTO huggingface dataset:
Patent NZ-522604-A (NZ)
Title: Knitted mesh fabric
Inventor: KOST DAVID WILLIAM
IPC: D04B21/18
Filed: 2002-11-14
Abstract: A knitted mesh fabric is disclosed, which includes a plurality of longitudinally and transversely extending knitted threads forming an open, generally planer framework with spaces defined between the threads; and a plurality of resiliently, longitudinally extendible threads laid in the open framework in at least one direction; the open framework being contracted in the at least one direction when the resiliently extendible threads remaining generally in the plane of the contracted framework and contacting into the space so as to partially close the spaces, whereby in use the fabric is stretchable in at least one direction causing the resiliently extendible threads to resiliently extend and the framework to extend so as to open the spaces between the framework threads.
Patent NZ-534044-A (NZ)
Title: Process for the production of 6.alpha.,9.alpha-difluoro-17.alpha.-(1-oxopropoxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17.beta.-carbothioic acid
Inventor: COOTE STEVEN JOHN
IPC: C07J31/00
Filed: 2003-02-03
Abstract: A process for preparing a compound of formula (II) or a salt thereof is disclosed. These compounds are used in the preparation of fluticasone propionate which is a corticosteroid of the androstane family which has potent anti-inflammatory activity and is widely accepted as a useful therapy for the treatment of inflammatory and allergic conditions such as rhinitis and asthma.
Patent NZ-537393-A (NZ)
Title: Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s)
Inventor: HOARAU DIDIER
IPC: A61K39/395
Filed: 2003-06-11
Abstract: Disclosed are stealth lipid nanocapsules consisting of a lipid core which is liquid or semi-liquid at ambient temperature, and an outer lipid envelope comprising at least one hydrophilic surfactant which is lipidic in nature, at least one lipophilic surfactant which is lipidic in nature and at least one amphiphilic derivative of poly(ethylene glycol), wherein the molar mass of the poly(ethylene glycol) component is greater than or equal to 1000 g/mol.
Patent NZ-539831-A (NZ)
Title: Process for preparing substituted imidazole derivatives and intermediates used in the process
Inventor: JUUJARVI PAIVI
IPC: C07D233/84
Filed: 2004-01-08
Abstract: Disclosed is a process for preparing substituted imidazole derivatives of formula (I) and acid addition salts thereof in which formula Y is -CH2- or -CO-, R1 is selected from the list consisting of H, halogen and hydroxyl, R2 is H or halogen and R3 is H or lower alkyl comprising the steps of a) halogenating a compound of formula (II) to obtain a compound of formula (III), b) reacting the compound of formula (III) thus obtained with an amine of formula R4NH2, wherein R4 is an easily removable leaving group, and an alkali metal thiocyanate, to obtain a compound of formula (IV), c) removing the mercapto group from the compound of formula (IV) to obtain a compound of formula (V), d) removing the group R4 from the compound of formula (V) to obtain a compound of formula (I).
Patent NZ-540715-A (NZ)
Title: Stable dispersible pharmaceutical compositions comprising an antibacterial agent
Inventor: BRITTEN NANCY J
IPC: A61K31/415
Filed: 2003-12-11
Abstract: Disclosed herein is a pharmaceutical composition comprising a vehicle that comprises (a) an amphipathic oil that is water dispersible and ethanol insoluble, (b) microcrystalline wax, and (c) a pharmaceutically acceptable non-aqueous carrier; said vehicle containing stably dispersed therein an antibacterial substance in an antibacterially effective amount. The composition is suitable for administration by intramammary infusion to a milk producing animal for treatment t and/or prevention of mastitis or other diseases of the udder, as well as for otic administration for treatment and/or prevention of an ear infection.
Patent NZ-544907-A (NZ)
Title: A system and method for facilitating on-line payment
Inventor: GRINBERG ALEXANDER
IPC: G06Q20/26
Filed: 2004-06-24
Abstract: A system and a method for facilitating on-line payment particularly for goods or services purchased via a merchant site on the Internet are disclosed. The system enables payment from an existing customer account at a financial institution, but does not require the user to provide credit card details. The payment is implemented in real-time from the customer account to a merchant account via a financial institution application such as an Internet banking website. An interface is provided which is initiated via the merchant site and which then interfaces the customer computer to the financial application having access to the customer computer's account. The customer can then enter payment details directly with the financial institution to pay the merchant directly for the transaction.
Patent NZ-545474-A (NZ)
Title: Ladder attachment with pivoted member to abut a wall for stability
Inventor: DAWSON JOHN
Filed: 2006-02-22
Abstract: A ladder attachment (50) to aid the stability of a ladder and/or provide a storage location for equipment on a ladder is disclosed. The attachment has a rigid and planar first member (51) that connects at a first end to a flat portion of a rung or top member (59) of the ladder. A rigid elongate second member (59) is pivotally connected (53) at a second end of the first member. The second member is adapted to abut a wall or structure.
Patent NZ-545882-A (NZ)
Title: A lock and key system with extra code combinations
Inventor: WIDEN BO
IPC: E05B27/00
Filed: 2004-09-13
Abstract: The invention is a lock (200) and key (100) system which uses two key edges to provide greater security and more code combinations. The blade of the key has two wave-like guiding surfaces, a conventional upper surface (103) and a lower side surface (104) . The upper surface engages with conventional tumblers (205). The lower surface (104) engages with side locking tumblers (206) which, when engaged withdraws a side locking mechanism (213). When both sets of tumblers (205, 206) are engaged and the side locking mechanism (213) is withdrawn the key is able to turn in the lock.
Patent NZ-547316-A (NZ)
Title: 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
Inventor: XUE CHU-BIAO
IPC: A61K31/4439
Filed: 2004-12-16
Abstract: Disclosed are 3-cycloalkylaminopyrrolidine derivatives of formula (I), or pharmaceutically acceptable salts thereof, wherein the substituents are disclosed within the specification. Also disclosed is the use of the said 3-cycloalkylaminopyrrolidine derivatives for the manufacture of a medicament for the modulation or treatment of chemokine receptor activity, inflammation, rheumatoid arthritis, atherosclerosis, neuropathic pain, Iupus, systemic lupus erythematosus, restenosis, immune disorders, cancer and transplant rejection.
Patent NZ-549251-A (NZ)
Title: Sulphonylpyrroles as HDAC inhibitors
Inventor: MAIER THOMAS
IPC: A61K31/40
Filed: 2005-03-10
Abstract: Disclosed is a compound of formula I wherein the substituents are disclosed within the specification and a salt thereof. Also disclosed is the use of the compound of formula I for treating benign and/or malignant neoplasia.
Patent NZ-552698-A (NZ)
Title: Support rail for a bicycle saddle shell
Inventor: RIONDATO FRANCESCO
IPC: B62J1/08
Filed: 2005-07-28
Abstract: A support rail for a bicycle saddle shell is disclosed. The support rail presents two perfectly symmetrical portions in relation to the longitudinal plane of symmetry of the saddle. Both of the portions present a first end section arranged in a substantially horizontal manner in relation to its normal position after it has been mounted on the saddle. The first sections are integrally formed with sloped second sections, which are integrally formed with third sections arranged in a substantially horizontal manner or slanted upwards for a maximum angle of 5ø. The third sections are longer than either the first sections or second sections, and are formed integrally with straight fourth sections, which slope outwards from the centre line. The uppermost part of the two fourth sections is formed integrally with two fifth sections, turning in an inward direction to reciprocally converge towards the centre line of the device, thus forming with the two fourth sections a substantially L-shaped structure. The ends of the two fifth sections of the structure being formed integrally with two short straight sixth sections which are united reciprocally by a single semicircular structure, whose lower vertex is positioned exactly at the longitudinal centre line of the device. A bicycle saddle shell for use with the support rail is also disclosed. In the shell, at the rear part of the lower surface are two prismatic structures having a substantially trapezoidal cross-section, each presenting a channel on its surface, inside which is housed most of the portions of the fifth and sixth sections of the rail. Each of the two prismatic structures further includes a cover plate designed to be positioned over the sections of the rail enclosing them between the cover plates and the prismatic structures. Each of the cover plates has a number of holes in which self-threading screws, screwable into the shell, can be inserted, thus determining the stable fixation of the cover plates and therefore the rail, to the shell underneath.
Patent NZ-562160-A (NZ)
Title: Setting tool
Inventor: MONAHAN PATRICK
IPC: B21D9/05
Filed: 2006-04-26
Abstract: A tool (20) and method for installing collapsible inserts. The tool (20) includes a stabilizing handle (26) which is threaded onto a tool body (24). The tool body (24) is threaded onto a tool shaft (22). In use, a collapsible insert (34) is threaded onto the tool (20) and the insert (34) is positioned in a hole (102) in a workpiece (104). An actuating handle (38) of the tool (20) is then rotated, while holding the stabilizing handle (26), to cause the collapsible insert (34) to collapse, thereby installing the insert (34) relative to the workpiece (104). Once the insert (34) has been collapsed using the tool (20), the actuating handle (38) is rotated in the opposite direction, while holding the stabilizing handle (26), to disengage the tool (20) from the insert (34). Then, a hanger (106) is threadably inserted into the collapsed insert (34) and a threaded rod (124) is threaded into the hanger (106). Alternatively, the threaded rod (124) is directly threadably engaged with the collapsed insert (34), without need for a hanger (106).
Patent NZ-562682-A (NZ)
Title: Compositions and methods for the improvement of plants
Inventor: PUTHIGAE SATHISH
Filed: 2007-10-19
Abstract: Disclosed is an isolated polynucleotide comprising: a) a sequence encoding a polypeptide with at least 70% identity to any one of the amino acid sequences of SEQ ID NO: 3, 6, 9 and 12, wherein the polypeptide increases or decreases in a plant, tolerance to at least one environmental stress selected from drought, cold, freezing, heat and salinity; b) a fragment of at least 15 nucleotides in length, of the sequence of a); c) the complement of the sequence of a); d) the complement of the sequence of b); or e) a sequence, of at least 15 nucleotides in length, capable of hybridising to the sequence of a) under high stringency conditions. Also disclosed are host cells containing said polynucleotide, plants containing said host cells and methods for producing said plants.
Patent NZ-569311-A (NZ)
Title: Real time binding analysis of antigens on a biosensor surface
Inventor: MADISON LARA
IPC: G01N33/543
Filed: 2006-11-29
Abstract: Disclosed is a method of detecting binding of a binding partner to a phage comprising: (a) immobilizing a crude phage preparation, unconcentrated phage preparation, non-homogenous phage preparation, concentrated phage preparation or combination thereof on a biosensor, wherein the crude phage preparation, unconcentrated phage preparation, non-homogenous phage preparation, concentrated phage preparation or a combination thereof is immobilized to the biosensor by: (i) an antibody specific for a phage coat protein or an antibody fragment specific for a phage coat protein; or (ii) passive immobilization; (b) contacting the biosensor with the binding partner; (c) detecting binding of the binding partner to the phage immobilized on the biosensor.
Patent NZ-572003-A (NZ)
Title: Two-piece, internal-channel osmotic delivery system flow modulator with spiral fluid channel
Inventor: LAUTENBACH SCOTT D
IPC: A61M5/142
Filed: 2007-05-30
Abstract: Disclosed is an osmotic delivery system flow modulator (200). The modulator includes an outer shell (202), an inner core (204), and a fluid channel (206). The outer shell is constructed and arranged for positioning in an opening of a reservoir of an osmotic delivery system, and includes an inner surface (212). The inner core is inserted in the outer shell, and includes an outer surface (210). The fluid channel has a spiral shape defined between the inner surface of the outer shell and the outer surface of the inner core, and is adapted for delivery of an active agent formulation from the reservoir of the osmotic delivery system.
Patent NZ-574045-A (NZ)
Title: Film-based cellular matrix
Inventor: MARSON JAMES
IPC: E04C2/36
Filed: 2003-12-09
Abstract: A polymeric collapsible matrix of single walled cells includes rows I, II, III, etc of open ended hollow prisms formed from a flexible sheet-like material. Each prism in a row has a perimeter enclosing wall of wall segments one of which is shared with a directly adjacent prism of the row. The adjacent prisms of a row are orientated alternately to form a repeating sequence of prism orientations. The upper and lower boundaries of each row are constant, and when the matrix is in the expanded state the rows do not overlap or interleave one with the other. Two methods for constructing the matrix are disclosed, and the method claimed in claim 19 is the method that is claimed in claim 1 of the parent patent 541180 which has been surrendered under Section 43 of the Patents Act 1953.
Patent NZ-575034-A (NZ)
Title: A connector cover, typically flash drive, with pivtol end contacts and covered by pivotal cover
Inventor: WOFFINDIN MICHAEL FRANCIS
Filed: 2009-02-20
Abstract: An electrical connector, typically a USB flash drive 100, has contacts 104 and surround which can pivot about an axis in area 107 to facilitate a cover 102 being able to be pivotally moved to cover the contacts and surround so as to minimise the necessary longitudinal extent of the connector.
Patent NZ-583497-A (NZ)
Title: A means of stripping concrete formwork from a concrete surface
Inventor: ROSATI WASYL
IPC: E04G11/54
Filed: 2008-08-21
Abstract: Disclosed is a frame for use with formwork to support the formwork for concrete casting and for stripping formwork from a concrete surface. A frame is moveable between a first and second position relative to the framework. In the first position, the frame supports and holds formwork in place for concrete casting. The frame retracts to a second position so as to lower the formwork away from the concrete surface. Sufficient force is applied to the formwork as the frame retracts to the second position to strip it from the concrete surface. The invention provides a means of both supporting formwork during concrete casting as well as a means of stripping and lowering the formwork after the concrete is cast.
Patent NZ-584330-A (NZ)
Title: Markers of endothelial cells and uses thereof
Inventor: KREMMIDIOTIS GABRIEL
IPC: C12N5/00
Filed: 2008-10-02
Abstract: 584330 Provided is an in vitro method of identifying an agent which selectively interacts with activated endothelial cells, comprising: (a) providing activated endothelial cells in which the expression of beta I tubulin is higher than in quiescent endothelial cells; (b) providing quiescent endothelial cells in which the expression of beta III tubulin is higher than in activated endothelial cells; ( c) adding a candidate agent to the activated cells in (a) ; (d) adding a candidate agent to the quiescent cells in (b) ; (e) determining the effect of the candidate agent on proliferation of the activated cells; and (f) determining the effect of the candidate agent proliferation of the quiescent cells; wherein a candidate agent which reduces proliferation of activated endothelial cells more than it reduces proliferation of quiescent endothelial cells is an agent which selectively interacts with activated endothelial cells.
Patent NZ-584343-A (NZ)
Title: An adjustable anglers landing net holster that hold the net vertically in the small of the back attached to a belt
Inventor: SMITH WAYNE TRACY
IPC: A01K75/00
Filed: 2010-05-22
Abstract: A landing net holster for anglers is disclosed. The holster is able to hold a net (14) in the small of an anglers back and is adjustable to accommodate nets (14) with different sized handles. The holster has a base including means for attaching to a waist belt (12). A net retention sleeve (48) is coupled to the base for receiving and holding the handle of the net (14). The sleeve (48) is an open-ended elongated tube whose circumference may be adjusted thus allowing the sleeve (48) to receive and secure nets (14) of different sizes and or shapes. A number of methods for adjustment of the sleeve (48) circumference are disclosed.
Patent NZ-588667-A (NZ)
Title: Use of spinosyns for controlling earth mite and springtail pests affecting crops and pastures
Inventor: DOWNARD PAUL
IPC: A01N43/22
Filed: 2010-10-19
Abstract: A method of controlling a pest selected from the group consisting of ground dwelling mites and springtails is disclosed, wherein the method includes the step of applying to an area of earth where control is desired, prior to the emergence of seedlings contained therein from the earth, an inhibitory or inactivating amount of a pesticidal compound selected from the group consisting of spinosyns, synthetically-modified spinosyns, and derivatives, salts and mixtures thereof. The pests that are controlled by this method include red-legged earth mite (Halotydeus destructor), blue oat mite (Penthaleus major) and a springtail, such as lucerne flea (Sminthurus viridis). Said pesticidal compound is preferably provided in a pesticidal composition selected from the group consisting of water-soluble, water-suspension, and emulsifiable formulations, and water-dispersible granules.
Patent NZ-588743-A (NZ)
Title: Use of a protein kinase C (PKC) alpha inhibitor for treating inflammation of the skin
Inventor: TENNENBAUM TAMAR
IPC: A61P17/02
Filed: 2004-07-15
Abstract: Disclosed is the use of PKC isoform activators and inhibitors for attenuating inflammation which results from a skin wound. The PKC isoform can be PKC-alpha and the inhibitor can be the n-myristoylated PKC-alpha pseudosubstrate peptide. A growth factor or insulin can be used in conjunction with the PKC inhibitor or activator.
Patent NZ-590377-A (NZ)
Title: Oxazolopyrimidines as edg-1 receptor agonists
Inventor: KADEREIT DIETER
IPC: A61P11/00
Filed: 2009-07-02
Abstract: Disclosed are oxazolopyrimidines represented by general formula (I), in any of its stereoisomeric forms, or a mixture of stereoisomeric forms in any ratio, or a physiologically acceptable salt thereof, or a physiologically acceptable solvate of any of them, wherein A is -CR6R7. Also disclosed is a the use of the compounds of formula (I) for treating cardiovascular diseases, coronary heart disease, coronary artery disease, stable or unstable angina pectoris, Prinzmetal angina, acute coronary syndrome, myocardial infarction. cardiac insufficiency, heart failure, cardiac ischemia and/or reperfusion injury, stroke, thrombosis, atherosclerosis, endothelial dysfunction, peripheral arterial occlusive disease, restenosis,vasculopathy, endothelial damage after PTCA, hypertension, vascular permeability disorders, edema, wound healing disorders, sepsis, diabetes, diabetic complications, diabetic cardiomyopathy, retinopathy, renal diseases, nephropathy, respiratory diseases, inflammatory diseases, autoimmune diseases, multiple sclerosis, neurodegenerative diseases, CNS injury or cancer, for modulating angiogenesis, arteriogenesis, or vasculogenesis, or for cytoprotection, renoprotection or cardioprotection.
Patent NZ-591780-A (NZ)
Title: Method and system for improved process parameter control of a liquid composition in a reverse electro-enhanced dialysis (reed) system
Inventor: GARDE ARVID
IPC: B01D61/42
Filed: 2009-09-04
Abstract: 591780 Disclosed is a method for process parameter control of a liquid composition in a bioreactor or live fermentation process, wherein said process parameters are selected among pH, concentration of target ions and/or conductivity of said liquid composition, by extracting inhibitors like organic acid ions to improve productivity and longevity of cell growth and/or to regulate metabolite production comprising at least one step of passing said liquid through a first Reverse Electro-Enhanced Dialysis (REED) membrane stack and a second REED membrane stack, each stack having: i) at least two ion-exchange membranes defining a first chamber for a first liquid there between; ii) at least two further chambers for a second liquid, each further chamber being located adjacent to the at least one first chamber; iii) a set of end membranes; iv) means for applying an electric field over each membrane stack by means of at least two electrodes; v) means for reversing the direction of the electric field within said membrane stacks; wherein the direction of the electric field within said first membrane stack is reversed at asynchronical intervals of time relative to the reversal of the electric field within said second membrane stack, and wherein said REED membrane stacks are operated in parallel. Also disclosed is a system comprising the REED membrane stack to control process parameters of a liquid composition in a bioreactor or live fermentation process by extracting inhibitors like organic acid ions to improve productivity and longevity of cell growth and/or to regulate metabolite production
Patent NZ-592738-A (NZ)
Title: APJ receptor compounds attached to a lipophilic tether through a carbonyl linker
Inventor: JANZ JAY
IPC: C07K7/06
Filed: 2009-11-04
Abstract: Disclosed is a compound represented by Formula I: T-L-P, or pharmaceutically acceptable salts thereof, wherein: P is a peptide comprising at least thirteen contiguous amino-acid residues derived from an intracellular il loop of the APJ receptor; L is a linking moiety represented by C(O) and bonded to P at an N terminal nitrogen of an N-terminal amino-acid residue; and T is a lipophilic tether moiety bonded to L where the C-terminal amino acid residue of P is optionally functionalized, wherein P is derived from the il loop and is represented by the following structural formula or pharmaceutically acceptable salts thereof, X1-X2-X3-X4-X5-X6-X7-X8-X9-X10-X11-X12-X13-X14-X15-X16-X17-X18-X19-Ri, wherein: X1 is absent or a threonine; X2 is absent or a valine; X3 is absent or a phenylalanine; X4 is absent or an arginine; X5 is a serine; X6 is a serine; X7 is an arginine; X8 is a glutamic acid; X9 is a lysine; X10 is an arginine; X11 is an arginine; X12 is a serine; X13 is an alanine; X14 is an aspartic acid; X15 is an isoleucine; X16 is a phenylalanine; X17 is an isoleucine; X18 is absent or an alanine; X19 is absent or a serine residue; Ri is OR2 or N(R2)2; each R2 is independently hydrogen or (C1-C10)alkyl; and from 0 to 1 amino acid residues are present in the D configuration and wherein from 0 to 1 amino acid residues may be substituted by alanine